Staphylococcus aureus ribonuclease-P-protein subunit (RnpA) is a promising antimicrobial target that is a key protein component for two essential cellular processes, RNA degradation and transfer-RNA (tRNA) maturation. The first crystal structure of RnpA from the pathogenic bacterial species, S. aureus, is reported at 2.0 Å resolution. The structure presented maintains key similarities with previously reported RnpA structures from bacteria and archaea, including the highly conserved RNR-box region and aromatic residues in the precursor-tRNA 5 0 -leader-binding domain. This structure will be instrumental in the pursuit of structure-based designed inhibitors targeting RnpA-mediated RNA processing as a novel therapeutic approach for treating S. aureus infections.
Introduction
Ribonuclease P (RNase P) is a ribonucleoprotein complex that in bacteria consists of a catalytic RNA ribozyme component (P RNA) and one relatively smaller protein component known as ribonuclease P protein (RnpA) . RNase P catalyzes the cleavage of the 5 0 -leader sequence from all precursor-transfer-RNA (ptRNA) and both components, P RNA and RnpA, are essential in vivo (Schedl & Primakoff, 1973; Waugh & Pace, 1990; Evans et al., 2006) . Alternatively, RnpA is also a key element in the messenger RNA (mRNA) degradosome discovered in both Staphylococcus aureus and Bacillus subtilis (Roux et al., 2011) . Because RnpA plays a critical role in two essential cellular processes in the pathogen S. aureus it has been postulated that targeting RnpA-mediated RNA metabolism may represent a promising new antibiotic therapeutic strategy for treatment of S. aureus infections (Eidem et al., 2012 (Eidem et al., , 2015 Olson et al., 2011; Willkomm et al., 2003 Willkomm et al., , 2010 Drainas, 2016; Berchanski & Lapidot, 2008) . Crystal structures for P RNA, RnpA, and the full RNase P complex have been determined from non-pathogenic bacterial species such as Thermotoga maritima (Kazantsev et al., 2003 (Kazantsev et al., , 2005 Reiter et al., 2010; Torres-Larios et al., 2005) and B. subtilis (Daniels et al., 2014; Stams et al., 1998) as well as a recent NMR solution structure for T. maritima RnpA (Zeng et al., 2018) . Additionally, the NMR structure of S. aureus RnpA has been reported (PDB entry 1d6t, Spitzfaden et al., 2000) ; however, the impact of the structure for drug-discovery purposes is severely limited because of the lack of a deposited NMR chemical shift data set. This lack of backbone chemical shifts ISSN 2053-230X # 2018 International Union of Crystallography makes it impossible to map ligand-binding sites using chemical-shift perturbation unless one re-collects the data and assigns the backbone resonances to the respective residues. Additionally, as is typical of NMR structures, the result of structure determination provides an ensemble of structures that satisfy NOE-based distance criteria. Individual structures in the ensemble may show considerable variations relative to a calculated average structure. While these variations may reflect important solution-state dynamics they tend to 'smear out' atomic positions over fluctuating segments, resulting in higher uncertainties in atomic positions in these segments. For these reasons an X-ray structure of S. aureus RnpA would be an improved tool for structure-based drug discovery, with the NMR structure providing complementary information on dynamics. Therefore, we set out to determine the S. aureus RnpA crystal structure in support of structure-based drug discovery targeting RnpA-mediated RNA degradation.
Materials and methods

Macromolecule production
An alternative protocol for protein production was employed compared with the NMR structure paper. The gene coding for S. aureus RnpA (4-117) in the pET-30 Ek/LIC::RnpA vector (Eidem et al., 2015) was polymerasechain-reaction (PCR) amplified using forward and reverse primers shown in Table 1 containing the NcoI and the XhoI restriction enzyme site (underlined), respectively. A tryptophan (W) residue was introduced by the forward primer to the N-terminus of RnpA for the convenience of monitoring protein purification with a UV detector. The subsequent PCR product was digested and ligated into the pHis-Parallel2 vector encoding a 6Â His fusion tag (underlined) and a tobacco etch virus (TEV) protease-cleavage site (#) (MSYYHHHHHHDYDIPTTENLYFQ#GAMGW-RnpA). The sequence was verified by sequencing analysis at the Purdue Genomics Core Facility and the plasmid DNA was transformed into competent Escherichia coli BL21 (DE3) Rosetta cells (Novagen). Expression transformants were cultured in Luria Broth (LB) medium containing 100 mg ml À1 ampicillin with shaking at 225 rev min À1 at 310 K to an OD 600 nm ' 0.6. Protein expression was induced with 300 mM isopropyl -D-1-thiogalactopyranoside (IPTG) for 4 h. Cells were pelleted by centrifugation at 3724g for 15 min and stored at À80 C. The pellet was resuspended in buffer A (50 mM sodium phosphate buffer, 300 mM sodium chloride, pH 7.4) and lysed by sonication the following morning. Debris was removed by centrifugation at 14 000g for 1 h, and supernatant was purified on a 5 ml Ni 2+ -NTA affinity column (GE Healthcare Bio-Sciences) with an Ä KTA-FPLC highperformance liquid chromatography system (GE Healthcare Bio-Sciences). Proteins eluted in a single peak with a linear imidazole gradient (0-500 mM) with buffer A and buffer B (1 M imidazole, 50 mM sodium phosphate buffer, 300 mM sodium chloride, pH 7.4). Fractions under the peak were analyzed by Coomassie-stained SDS-PAGE before being pooled together, mixed with 0.5 mM EDTA and 1 mM DTT, and incubated with TEV (200:1, v:v) for 48 h at 277 K. The subsequent cleavage product was purified in the same manner as the supernatant, and eluted protein was further purified by gel filtration in buffer C (20 mM Tris pH 7.4, 200 mM sodium chloride) with a HiPrep Sephacryl S200 column (GE Healthcare Bio-Sciences) on the Ä KTA-FPLC chromatography system to remove aggregates. Fractions were analyzed by Coomassie stained SDS-PAGE, and those with >95% purity were pooled, concentrated to 1 mg ml À1 , and stored at 277 K for short-term use. Macromolecule-production information is summarized in Table 1 .
Crystallization
The S. aureus RnpA protein sample was concentrated by centrifugation at 14 000g in an Amicon Ultra centrifugal filter (cutoff MW 3 kDa) to 12 mg ml À1 , and screened using commercial sparse-matrix crystallization screens available to our laboratory, MemGold TM HT-96 and MemGold2 TM HT-96 (Molecular Dimensions) (Jancarik & Kim, 1991 ) on a TTP LabTech Mosquito Crystal crystallization robot using the hanging-drop vapour-diffusion method at room temperature. Crystals produced from the screens were flash-cooled by direct plunging into liquid nitrogen with no extra cryoprotectants. Crystallization information is summarized in Table 2 .
Data collection and processing
X-ray diffraction data were collected at the Argonne National Laboratory (Chicago, IL) and were processed using Table 1 Macromolecule-production information. -2000 (Otwinowski & Minor, 1997 . Data were collected from two crystals, one diffracting to 2.0 Å resolution and the other to 2.6 Å resolution. The higher resolution data is presented herein. However, an ex post facto analysis of the data with online server STARANISO (http:// staraniso.globalphasing.org) showed it to be highly anisotropic, presumably a factor behind the relatively low CC 1/2 value in the highest resolution shell (Table 3) .
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Structure solution and refinement
The structure of S. aureus RnpA was determined by molecular replacement with Phaser (McCoy et al., 2007) in PHENIX using the average NMR structure of RnpA as the search model (PDB entry 1d6t). Refinement was performed with PHENIX (Adams et al., 2010) and Coot (Emsley et al., 2010) . The coordinates have been deposited as PDB entry 6d1r, and the refinement statistics are provided in Table 4 . Structure figures were prepared using the PyMOL molecular graphics system (Schrodinger, LLC) and the Ramachandran plot was calculated using Coot.
Structure alignment
The published NMR structure for RnpA (1d6t) was averaged in PyMol using the average three-dimensional Python script (available from the Cameron Mura laboratory, University of Virginia, http://muralab.org/~cmura/PyMOL/ pymol_mainFrame.html). The average NMR structure was aligned to the crystal structure and the backbone r.m.s.d. for the alignment was recorded using PyMol.
Sequence alignment
The sequence of S. aureus RnpA was aligned with RnpA's from eight other bacteria, four Gram-positive (B. subtilis, T. maritima, Enterococcus faecalis, Streptococcus pneumoniae) and four Gram-negative (E. coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae), using the Clustal Omega webserver (Sievers et al., 2011) and the alignment graphic (Fig. 5 ) was prepared using ESPript 3.0 (Robert & Gouet, 2014) .
Results and discussion
3.1. Crystallization of S. aureus RnpA The S. aureus RnpA protein was crystallized using hangingdrop vapour diffusion with a protein solution in 20 mM Tris pH 7.4, 200 mM NaCl at a concentration of 12 mg ml À1 combined with a reservoir solution of 0.15 M phosphate buffer pH 6.5, 3.3 M (NH 4 ) 2 SO 4 at a 0.2:0.2 ml ratio (Table 1) . Two crystals (one shown in Fig. 1) were harvested and flash-cooled for data collection. Table 3 Data collection and processing.
Values for the outer shell are given in parentheses.
Diffraction source
Beamline 23 
Figure 1
Crystal of S. aureus RnpA in hanging-drop well prior to harvest.
Structure of S. aureus RnpA
The S. aureus RnpA-protein subunit crystallized in space group P321. The structure was determined at 2.0 Å resolution (PDB entry 6d1r) ( Table 3 ). The asymmetric unit of the crystal contained a single monomer of the protein. A total of 107 out of 117 of the residues were modelled. The final modelled residues contained 99% of residues in the favoured region and 1% in the allowed region with no outliers. The six N-terminal residues (GAMGWE) and four C-terminal residues (KKIK) were not modelled because of a lack of continuous density. Regions 12-16, 37-41 and 74-79 represent real-space R-value Z-score (RSRZ) outliers, however, these regions were somewhat disordered with relatively weaker electron density.
The overall architecture of S. aureus RnpA is similar to that of previous RnpA structures. The secondary structure is laid out in an 1 -1 -2 -3 -2 -4 -1 -3 sequence (Figs. 2 and 5) . The four -sheets are arranged next to one another 1 -2 -4 -3 from right to left as observed previously (Fig. 2, magenta ) (Spitzfaden et al., 2000) . Strands 1 -2 -4 orient antiparallel to each other while the 4 -3 are arranged in parallel. This creates a -sheet surface that is solvent exposed on one face with hydrophobic contacts on the opposite face. This surface is flanked by three -helices (Fig. 2, grey) , one on the frontbottom running perpendicular ( 1 , residues 12-21) and two behind ( 2 , residues 56-73, and 3 , residues 95-109) along with one 3 10 -helix ( 1 , residues 88-92). The hydrophobic face of the -sheets packs against the 2 and 3 helices to create a characteristic -fold conserved in ribonucleoprotein RNAbinding modules (Leulliot & Varani, 2001; Varani, 1997) .
Helix 1 is positioned perpendicularly across the bottom of the solvent-exposed side of the -sheet face. This creates a groove lined with aromatic and/or hydroxyl-containing residues (Phe15, Tyr19, Ser24, Tyr33 and Ser48; Fig. 3a , magenta sticks) that probably facilitate base-stacking and hydrogenbonding interactions with single-stranded RNA substrates (Spitzfaden et al., 2000; Reiter et al., 2010 Reiter et al., , 2012 . Two highly conserved lysine residues, Lys51 and Lys52 (Fig. 3a, green  sticks) , flank the opening of the RNA-binding groove opposite Phe15 and Ser48 to provide stabilizing electrostatic interactions with the substrate RNA backbone as previously described (Reiter et al., 2010 (Reiter et al., , 2012 . The motif of highest phylogenetic conservation in the RnpA proteins is the RNR box motif represented by residues 59-67 ( Fig. 3b, salmon  sticks) . This positive-charged sequence is responsible for facilitating electrostatic contacts with the catalytic P-RNA portion of the complex. These residues reside at the top half of 2 and are solvent exposed, poised to form the required interactions with P RNA.
The crystal structure was aligned with the average solutionstate NMR structure (Fig. 4) . This indicated a root-meansquare deviation (r.m.s.d.) of 1.2 Å between backbone atoms. In particular, 1 and 2 were more ordered in the crystal structure compared with the NMR structure. Additionally, the overall position of the -helices was also shifted toward the centre of the molecule compared with the average NMR structure, giving the crystal structure a slightly more compact appearance. This difference between the crystal structure and the average NMR structure perhaps reflects local protein dynamics, as can be seen from higher-than-average B factor in this helix (see Fig. S2 in the supporting information).
Sequence alignment of S. aureus RnpA with eight other bacterial RnpAs demonstrates the importance of the substrate and P-RNA-binding RNR-box (Fig. 5 ). These residues are highly conserved across all species and necessary for the proper functioning of the RNase-P holoenzyme in bacterial cells. The high phylogenetic and structural conservation of these basic amino acids explains the ability for RnpA subunits of bacterial species to be used interchangeably with P RNA of other bacterial species (Guerrier-Takada et al., 1983) .
The surface representation displays the RNA-binding groove that is formed from the -sheet face meeting 1 (Fig. 3c ). An overlay of the 5 0 -leader-sequence ptRNA from the RNase-P-ribonucleoprotein complex structure from T. maritima (PDB entry 3q1r, Reiter et al. 2010) with the S. aureus RnpA (Fig. 6) shows the phosphate backbone of the 5 0 -leader sequence (orange sticks) fitting into the channel created by the -sheet face with 1 . While we do not have a 5 0 -leader-sequence-bound structure to depict the structural dynamics upon substrate binding, the B-factor measurements for the crystal structure clearly indicate there is flexibility along the substrate-binding site (see Fig. S2 in the supporting Sequence similarity depicted by shaded boxes: Red box-white character (100% identity), red character (>70% residue similarity), blue box (>70% residue similarity across group). Secondary structure sequences: helices (curly line) and sheets (arrows). 5 0 -leader-ptRNA substrate-binding residues indicated by * and RNR-box motif indicated by^.
Figure 6
S. aureus RnpA (grey, transparent surface) overlaid with the phosphate backbone of 5 0 -leader sequence of ptRNA substrate (orange sticks, PDB entry 3q1r). information). Higher-than-average B-factor values are calculated, 1 indicating a degree of flexibility to accept and conform to leader-sequence binding. The rest of the ordered secondary structures appear to have medium-to-low B-factor values suggesting the rest of the protein is fairly rigid in this structural representation.
To summarize, this communication describes the crystallization conditions and X-ray structure for S. aureus RnpA. This work will provide an alternative approach to determine ligand-bound structural data in support of future structurebased drug discovery. This structure may also begin to shed light on the newly hypothesized role S. aureus RnpA plays in RNA degradation in addition to ptRNA maturation.
